Promises of Nanotherapeutics in Obesity

Trends Endocrinol Metab. 2019 Jun;30(6):369-383. doi: 10.1016/j.tem.2019.04.004. Epub 2019 May 21.

Abstract

The application of nanotechnology to medicine promises a wide range of new tools and possibilities, from earlier diagnostics and improved imaging, to better, more efficient, and more targeted therapies. This emerging field could help address obesity, with advances in drug delivery, nutraceuticals, and genetic and epigenetic therapeutics. Its application to obesity is still largely in the development phase. Here, we review the novel angle of nanotech applied to human consumable products and their specific applications to addressing obesity through nutraceuticals, with respect to benefits and limitations of current nanotechnology methods. Further, we review potential future applications to deliver genetic and epigenetic miRNA therapeutics. Finally, we discuss future directions, including theranostics, combinatory therapy, and personalized medicine.

Keywords: diabetes; epigenetics; gene therapy; miRNA; nanotechnology; obesity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Drug Delivery Systems
  • Epigenomics
  • Humans
  • MicroRNAs / metabolism
  • Nanoparticles / chemistry
  • Nanotechnology / methods
  • Obesity / metabolism*
  • Precision Medicine

Substances

  • MicroRNAs